Revenues double at pharma firm as it hails 'ground-breaking' clinical results
Chairman predicts "huge potential value" both for cancer patients and investors in the next period.
Alastair Smith Eliot Forster Coris Bioconcept Avacta Life Sciences Belgium Based Coris Bioconcept Launch Diagnosticsas
Source: thebusinessdesk.com